Ladenburg Thalmann Financial Services’s Avita Medical RCEL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$64K	Buy	+1,400	New	+$58.2K	﹤0.01%	3354

Other funds holding RCEL

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RCEL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Avita Medical (RCEL) in Q4 2019: 1,400 shares worth $64K. The stake represents ﹤0.01% of the portfolio and ranks #3354 among its holdings.

31 funds tracked by Wall St. Rank hold RCEL as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,400 shares of Avita Medical worth $64K as of Q4 2019.
Avita Medical was a new Ladenburg Thalmann Financial Services position in Q4 2019.
Avita Medical made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3354 holding.
31 funds tracked by Wall St. Rank held Avita Medical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.